In October, Brigham and Women's Hospital announced the launch of the Ann Romney Center for Neurologic Diseases. Through the Center, BWH will convene and lead a global collaboration in medical research to accelerate treatment, prevention and cures for five of the world’s most complex neurologic diseases, multiple sclerosis, Alzheimer's disease, Lou Gehrig's ALS, Parkinson’s disease and brain tumors. Read more.
Led by Principal Investigator Reisa Sperling, MD, Director of the Center for Alzheimer Research and Treatment at Brigham and Women’s Hospital (BWH), the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s (A4) study is a landmark international clinical trial evaluating the efficacy of anti-amyloid treatment in preventing memory loss due to Alzheimer’s disease among healthy older adults. Read more.
Neurologists at Brigham and Women’s Hospital (BWH) are using data captured by devices (such as sensors and smartphones), biologic profiling, clinical imaging, and neurologic examinations, in research studies designed to pinpoint factors that may determine an individual’s course of disease and to tailor treatment options that have not been previously available to patients. Read more.